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Purkinje cell injury, structural plasticity and
fusion in patients with Friedreich’s ataxia
Kevin C. Kemp1*, Amelia J. Cook1, Juliana Redondo1, Kathreena M. Kurian2, Neil J. Scolding1 and Alastair Wilkins1
Abstract
Purkinje cell pathology is a common finding in a range of inherited and acquired cerebellar disorders, with the
degree of Purkinje cell injury dependent on the underlying aetiology. Purkinje cells have an unparalleled resistance
to insult and display unique regenerative capabilities within the central nervous system. Their response to cell injury
is not typical of most neurons and likely represents both degenerative, compensatory and regenerative
mechanisms. Here we present a pathological study showing novel and fundamental insights into Purkinje cell
injury, remodelling and repair in Friedreich’s ataxia; the most common inherited ataxia. Analysing post-mortem
cerebellum tissue from patients who had Friedreich's ataxia, we provide evidence of significant injury to the
Purkinje cell axonal compartment with relative preservation of both the perikaryon and its extensive dendritic
arborisation. Axonal remodelling of Purkinje cells was clearly elevated in the disease. For the first time in a genetic
condition, we have also shown a disease-related increase in the frequency of Purkinje cell fusion and heterokaryon
formation in Friedreich's ataxia cases; with evidence that underlying levels of cerebellar inflammation influence
heterokaryon formation. Our results together further demonstrate the Purkinje cell’s unique plasticity and
regenerative potential. Elucidating the biological mechanisms behind these phenomena could have significant
clinical implications for manipulating neuronal repair in response to neurological injury.
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Introduction
Purkinje cells represent the sole output neuron of the
cerebellar cortex and thus changes in their function have
significant impact on the function of the cerebellum as a
whole. Purkinje cell pathology is a common finding in a
range of inherited and acquired cerebellar disorders,
with the degree of Purkinje cell injury dependent on the
underlying aetiology. The inherited ataxias are a group
of genetically heterogeneous conditions that share com-
mon clinical features that give rise to progressive ataxia,
with cerebellar injury and varying degrees of degener-
ation of other grey matter regions. Despite advances in
detection of precise genetic causes, no therapy has been
shown to prevent or slow the progression of disability in
these disorders.
Friedreich ataxia (FRDA) is the commonest autosomal
recessive ataxic condition, with 95 % of cases caused by
a homozygous GAA.TCC tri-nucleotide repeat expan-
sion mutation within intron 1 of the FXN gene [6] lead-
ing to transcriptional repression of the mitochondrial
protein frataxin [15, 46]. Patients with FRDA experience
insidious accumulation of neurological disability with
progressive trunk and limb ataxia, dysarthria, sensory
neuropathy and pyramidal weakness [17]. Neuropatholo-
gically, prominent areas of degeneration associated with
the disease are the dorsal root ganglia, peripheral nerves,
spinal cord, and cerebellum [23]. Hypoxic-ischemic
damage, due to cardiomyopathy or pulmonary complica-
tions, may also result in secondary brain injury. The
most significant lesion of the central nervous system
(CNS) is found within the dentate nucleus, located
within the deep white matter of each cerebellar hemi-
sphere. Selective atrophy of the large neurons and their
efferent myelinated fibres within the dentate nucleus is
severe, and is accompanied by abnormal dendritic
expansion and proliferation of the corticonuclear
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gamma-aminobutyric acid (GABA)-ergic terminals about
the dendrites of dying neurons, termed ‘grumose degen-
eration’. Remarkably, neuronal loss within the dentate
nucleus does not result in a significant level of retro-
grade atrophy within the Purkinje cell population and
the cerebellar cortex is generally intact [27]. Neverthe-
less, in some patients, Purkinje cell arborisation defects
have been reported and mild loss of these cells can be
seen at end-stage disease [25, 39].
Purkinje cells have a fairly unique and unparalleled
resistance to axonal injury within the CNS [12]. Their
response to insult is not typical of most neurons and
likely represents both degenerative, compensatory and
regenerative mechanisms. Pathological aberrations to
Purkinje cell morphology have been observed in cerebel-
lar disease, including axon torpedo formation and loss in
cyto-architecture [24, 33, 35, 44]. Structural plasticity in
the form of axon remodelling and intra-cortical branch-
ing can occur in Purkinje cells and axonal sprouting to
establish contact with surviving cells has been reported
in humans [1], which may represent a potential mechan-
ism by which cells attempt to re-establish cellular
connections and access trophic support [43]. The
phenomenon of bone marrow-derived cells (BMDCs)
fusing with Purkinje cells to form bi-nucleate hetero-
karyons has also been observed in a variety of experi-
mental models of cerebellar disease [2, 3, 8, 10, 11] and
also in patients with multiple sclerosis [22]. Accumulat-
ing evidence is raising new questions into the biological
significance of cell fusion, with the possibility that it
represents an important physiological phenomenon to
rescue damaged neurons [36, 51].
Understanding whether Purkinje cell axon remodel-
ling and/or fusion represent mechanisms by which
cerebellar functions can be maintained in genetic
cerebellar disease has important therapeutic conse-
quences. With the potential to protect and rescue
neuronal cells and restore homeostatic balance during
neurodegeneration, understanding the circumstances
in which they occur may lead to techniques to ma-
nipulate these mechanisms therapeutically. With this
in mind, using post-mortem cerebellum tissue, our
aims were to quantify the extent of Purkinje cell in-
jury and structural plasticity in FRDA, a condition
typically associated with Purkinje cell preservation, in
order to explore whether plasticity and fusion might
contribute to Purkinje cell survival.
Materials and methods
Patients
Post-mortem cerebellum samples from eight patients
with FRDA and five control patients were obtained
through collaboration with both BRAIN UK at the
University of Southampton, Southampton, UK and The
UK Multiple Sclerosis Tissue Bank at the Imperial
College, London, UK. The majority of cases pre-dated
genetic testing for FRDA and information regarding the
GAA.TCC tri-nucleotide repeat expansion lengths for
each FRDA case were not available. As a result, patients
had been clinically diagnosed as having FRDA and diag-
nosis had been confirmed during neuropathological
autopsy examination. Neuropathological reports at
post-mortem included: axonal loss and prominent
gliosis in the dorsal columns (more marked in the
gracile than the cuneate fasciculus), long tracts and
spinocerebellar tracts of the spinal cord; neuronal loss
in the dorsal nucleus of Clarke; gliosis within the
white matter of the cerebellum; neuronal shrinkage
and loss in the dentate nucleus with consequent atro-
phy of the superior cerebellar peduncles; and marked
depletion and gliosis of the gracile and cuneate
nuclei, vestibular nuclei and solitary tract of the me-
dulla. In the periphery, neuronal loss in the dorsal
root ganglia was documented and peripheral nerves
also showed demyelination and axonal degeneration.
For several FRDA cases, stained spinal cord and DRG
post mortem sections were available. Thus where pos-
sible, representative images of highly specific FRDA
lesions in the spinal cord, DRG were taken (Fig. 1a).
Control cerebellum samples were derived from
patients who had died from causes other than neuro-
logical disease (Table 1). All tissues were collected
with the donors’ fully informed consent via a pro-
spective donor scheme. At death, brains were re-
moved, fixed in neutral buffered formalin and tissue
blocks embedded in paraffin. For this study, 10 μm
sections were cut from cerebellar tissue of each
patient and mounted onto glass slides. In 10 μm sec-
tions, approximately half of a Purkinje cell perikaryon
could be encompassed.
Histochemical stains
For histological assessment, sections were deparaffinised
in Clearene, dehydrated in 100 % ethanol, hydrated in
distilled water, and stained with haematoxylin and eosin
(H&E), Bielschowsky silver staining or Luxol fast blue
with Cresyl violet.
Immunohistochemistry
Cerebellar sections were immuno-stained with antibodies
to rabbit anti-Calbindin-D28K (1:500) (Sigma-Aldrich, UK)
and HLA-DP DQ DR (1:800) (Dako, Cambridgeshire,
UK). Sections were deparaffinised in Clearene, dehydrated
in 100 % ethanol, hydrated in distilled water, and
immersed in 3 % hydrogen peroxide in methanol for
30 min to block endogenous peroxidase activity, rinsed
and microwaved in sodium citrate buffer (0.01 M,
pH 6.0, 5 min) or EDTA buffer (1 mM, pH 8,
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10 min) as appropriate and rinsed in phosphate-
buffered saline (PBS). Non-specific binding was blocked
with Vectastain blocking serum (20 min). After addition
of the primary antibody, sections were incubated over-
night at 4 °C. The sections were then rinsed in PBS be-
fore incubation for 20 min with secondary antibody
(Vectastain Biotinylated Universal antibody) and 20 min
with VectaElite ABC Complex (PK-6200, Vector La-
boratories, Peterborough, UK) followed by a 10-min in-
cubation with 3,3′-diaminobenzidine (DAB) and 0.01 %
H2O2. Sections were washed in water, immersed in
copper sulphate DAB enhancer (4 min), counterstained
with haematoxylin, dehydrated, cleared and mounted.
Images were acquired using an Olympus IX70 microscope
coupled with Image-Pro Plus software.
Immunofluorescence labelling
Sections were deparaffinised, hydrated and washed as
above. An antigen retrieval step was performed through
microwaving in sodium citrate buffer (0.01 M, pH 6.0,
5 min). Purkinje cells were labelled by single or double
immunofluorescence using rabbit anti-Calbindin-D28K
(1:500) (Sigma-Aldrich, UK), mouse anti-SMI-34 (phos-
phorylated neurofilament; 1:500) (Covance, US) and rat
Fig. 1 Neuronal injury in FRDA. Tissue sections derived from FRDA cases showing pathological lesions. a Characteristic FRDA lesions. (i) H&E
staining of the dorsal root ganglion showing shrunken neurones with severe eosinophilia of the perikaryon (black arrows), neuronal lipofuscin
accumulation (black triangle) and a nest of reactive satellite cells known as a nodule of Nageotte indicating ganglion neuronal cell degeneration
(red arrow). (ii) A section from the upper cord stained with Luxol fast blue and Cresyl violet showing marked dorsal column loss, more marked in
the gracile (black arrow) than the cuneate fasiculi (black triangle). There is also significant degeneration of the posterior spinocerebellar tracts (red
arrow). (iii) Luxol fast blue and Cresyl violet staining of the spinal cord showing loss of neurons from Clarke’s Column (black hatched area).
(iv) Grumose degeneration; disorganisation and proliferation of the Calbindin-D28K positive synaptic terminals situated around the large neurons
of the cerebellar dentate nucleus. b Signs of Purkinje cell injury. (i) Cerebellar sections immuno-labelled with Calbindin-D28K and counterstained
with haematoxylin (blue) showing the location of the Purkinje cell layer situated within the grey matter on the border of the molecular and
granular cell layers. (ii) Bielschowsky silver staining of the cerebellar cortex showing occasional loss of Purkinje cells leading to the presence of
‘empty baskets’ (white hatched areas). H&E staining showing the Purkinje cell layer with (iii) occasional shrunken Purkinje neurones with mild
eosinophilia of the perikaryon (black triangle), and (iv) Purkinje cells with loss of Nissl substance and shrunken basophilic homogenous nuclei
(black arrow). c (i) A cerebellar folium showing frequent Calbindin-D28K positive hypertrophic axons situated throughout the grey matter
(black arrows). (ii) Cerebellar cortex showing Calbindin-D28K positive axonal torpedoes (black arrows). The hatched area in (ii) represents the
higher magnified image (iii)
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anti-myelin basic protein (MBP) (1:100) (Serotec, UK).
Non-specific binding was blocked with 10 % normal goat
serum diluted in PBS containing 0.1 % triton. Sections
were incubated at 4 °C overnight with primary anti-
bodies. Sections were then washed in PBS and incubated
for 30 min in the dark with Alexa Fluor 555, goat anti-
mouse (1:500), Alexa Fluor 488, goat anti-rabbit (1:500)
or Alexa Fluor 555, goat anti-rat (1:500) (Invitrogen,
Paisley, UK), before being washed in PBS and mounted
in Vectashield medium containing the nuclear dye 4′6′-
diamidino-2-phenylindole (DAPI) (H-1200, Vector La-
boratories). Sections were imaged using either: 1) a Leica
SP5-AOBS confocal laser scanning microscope attached
to a Leica DM I6000 inverted epifluorescence micro-
scope with Leica Application Suite Advanced Fluores-
cence software and Volocity 3D image software
(PerkinElmer, USA); or 2) a Nikon C1 confocal micro-
scope and EZ viewer software.
Microscopy
Quantification of Purkinje cells
The total number of Purkinje cells was counted in FRDA
and control sections, scanning the entire length of the
Purkinje cell layer. Purkinje cells were identified based
on Calbindin positivity and their specific location. To ac-
count for the difference in section sizes and plane of cut-
ting, the length of the Purkinje cell layer was traced and
measured in each section using Image J software to ob-
tain the number of Purkinje cells per standardized unit
length (mm). For these sections, the length of Purkinje
cell layer was measured and the number of Purkinje cells
in each area counted.
Quantification of SMI-34 positive Purkinje cell perikarya
and axonal spheroids
The total number of axonal spheroids and Purkinje cell
perikarya positive for SMI-34 were counted in FRDA
and control sections, scanning the entire Purkinje cell
and granular layers.
Purkinje cell morphology
Using Image J software, the outline of each Purkinje cell
perikaryon (where the nucleus was clearly visible) was
traced and the area within subsequently calculated. The
total number of Purkinje cells with an abnormal peri-
karyal morphology were also counted in FRDA and con-
trol sections, scanning the entire length of the Purkinje
cell layer. To investigate changes in dendritic arborisa-
tion, concentric circles (with increasing diameter of 20
μm) were aligned on the centre of each Purkinje cell
perikaryon and the number of times each circle trans-
ected a dendrite was counted. Subsequently, the number
of transections per mm at each distance was calculated.
As the dendritic tree of Purkinje cells is not spherical,
only section orientations that resulted in a full display of
Purkinje cell arbor to be visualised were used for
quantification.
Purkinje cell axonal morphology
Specific changes in Purkinje cell axonal morphology
were counted in both FRDA and control sections,
Table 1 The characteristics of both FRDA and control cases used within this study
Case Pathological diagnosis Sex (M/F) Age (years) Cause of death
1 FRDA F 33 Heart Failure
2 FRDA M 46 Pneumonia
3 FRDA M 50 Pneumonia
4 FRDA/FRDA variant F 66 Pneumonia
5 FRDA F 42 Pneumonia
6 FRDA M 51 Pulmonary Embolism
7 FRDA M 47 Not known
8 FRDA F n/a Not known
mean 47.9
SE 4.5
1 Control M 82 Not known
2 Control M 88 Prostate cancer, bone metastases
3 Control M 68 Heart failure, fibrosing alveolitis, coronary artery artheroma
4 Control M 84 Bladder cancer, pneumonia
5 Control M 82 Myelodysplastic syndrome, rheumatoid arthritis
mean 80.8
SE 3.4
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scanning the entire length of the Purkinje cell and
granular layers. Changes included the number of
Calbindin-D28K positive thickened axons (a minimum 2-
fold increase in calibre of normal appearing axons),
thickened recurrent collaterals (hypertrophic collateral
branch attached to the corticofugal axon with a mini-
mum 90° turn back towards the Purkinje cell layer) and
thickened arciform fibres (hypertrophic axons with a
minimum 90° turn back towards the Purkinje cell layer).
Both Calbindin-D28K positive axonal branching (axons
with at least one branch point not defined as a collat-
eral) and terminal axonal sprouting (a network of fine
nodular/branched processes projecting from the intact
axon) were also counted [1, 43]. For these sections, the
length of Purkinje cell layer was measured and the num-
ber of Purkinje cells in each area calculated. All axonal
changes were then expressed as either frequency per
standardized unit length (100 μm) or frequency per
Purkinje cell.
Quantification of Purkinje cell heterokaryons
For identification of bi-nucleate Purkinje cell hetero-
karyons, cerebellar sections immuno-labelled for
Calbindin-D28K were viewed using a Leica SP5-AOBS
confocal laser scanning microscope attached to a Leica
DM I6000 inverted epifluorescence microscope. Each
section was scanned along the entire length of the
Purkinje cell layer, situated between the granular cell
layer and molecular layer, for Purkinje cell bodies con-
taining two separate nuclei. At least 2000 Purkinje cells
from each patient sample were examined, allowing for
the determination of the frequency of bi-nucleate
Purkinje cells. All bi-nucleate Purkinje cells were con-
firmed on the confocal microscope by obtaining serial
sections throughout the whole Purkinje cell body. All
Z-stack and 3-dimensional imaging was created using
both Leica Application Suite Advanced Fluorescence soft-
ware and Volocity 3D image software (PerkinElmer, USA).
Quantification of microglial cells
All HLA-DP DQ DR positive cells were counted, using
at least 18 randomly assigned fields per case, within the
white matter and grey matter regions of the cerebellum.
The number of HLA-DP DQ DR positive cells per mm2
was subsequently calculated.
Statistical analysis
The analysis was performed using GraphPad Prism
(GraphPad Software Inc, USA). For all tests, values are
expressed as the mean ± SE from at least five independ-
ent cases, taking P <0.05 to represent statistical signifi-
cance. Data between two groups were analysed using
either unpaired t-tests or Mann-Whitney U tests. Statis-
tical comparisons for over two groups were analysed
using either one-way or two-way analysis of variance
(ANOVA) with post hoc testing between groups where
appropriate. Pearson’s correlation was used to analyse
relationships between two sets of data.
Results
Identification of cerebellar Purkinje cells
To identify Purkinje cells within cerebellar tissue, sec-
tions were immuno-labelled for the calcium-binding
protein Calbindin-D28K. Purkinje cells were readily iden-
tified based on their unique morphology and location;
their perikaryon situated within the Purkinje cell layer
positioned between the granular cell and molecular
layers (Fig. 1b). In control cases, Purkinje cells showed a
typical morphology; with extensive dendritic arborisation
climbing through the molecular layer toward the surface
of the cortex, with its axon originating at the opposite
(basal) pole of the cell perikaryon, passing through the
granular layer (where it becomes myelinated) towards
the white matter, sending inhibitory efferent projections
to the deep cerebellar nuclei.
Purkinje cell injury in Friedreich’s ataxia
In FRDA cases, Purkinje cells showed several distinct
features. Disorganisation and proliferation of Calbindin-
D28K positive synaptic terminals surrounding soma and
dendrites of the dentate neurons, termed ‘grumose
degeneration’ was present (Fig. 1a). Using H&E staining,
the Purkinje cell layer showed occasional shrunken
Purkinje neurones with mild eosinophilia of the peri-
karyon, loss of Nissl substance and shrunken basophilic
homogenous nuclei (Fig. 1b). The occasional loss of
Purkinje cells leading to the presence of ‘empty baskets’
(the axon terminals of basket cells that typically enwrap
the Purkinje cell perikaryon appear to surround an
empty space) were observed using Bielschowsky silver
staining (Fig. 1b). A marked incidence of Purkinje cell
axonal thickening and swellings (torpedoes) situated
within the granular layer was also evident (Fig. 1c).
Dual-immunolabelling of cerebellar sections with
Calbindin-D28K and SMI-34 (anti-phosphorylated neuro-
filament) was used to further characterise Purkinje cell
axonal morphology and injury [44]. FRDA cases had no-
ticeable changes in axonal morphology (hypertrophy or
swelling of the axon segment) compared to controls;
these structures appearing to arise from the proximal
end of the corticofugal axon, being strongly immuno-
reactive for both Calbindin-D28K and SMI-34 (Fig. 2a
and b). A small number of Calbindin-D28K/SMI-34 tor-
pedoes were seen in control cases, however the number
of Calbindin-D28K/SMI-34 torpedoes per Purkinje cell
body was significantly increased in FRDA cases com-
pared to controls (p <0.05) (Fig. 2c).
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Morphological changes in both the Purkinje cell peri-
karyon and dendritic compartments were examined
(Fig. 3a-h). No significant differences were found in the
number of Purkinje cells per unit length (mm) of the
Purkinje cell layer (Fig. 3b). In addition, no differences
in overall Purkinje cell perikaryon size were evident be-
tween patient groups (Fig. 3c). However, Purkinje cells
in FRDA cases with an associated axon torpedo showed
a significant reduction in perikaryon size when com-
pared to controls (p <0.05) (Fig. 3c). This sub-group of
Purkinje cells commonly displayed a ‘deflated’ and
shrunken perikaryal morphology (Fig. 3f ); a proportion
of these cells also presented with marked SMI-34 accu-
mulation within their perikaryon/dendrites (Fig. 3f ).
Both the percentage of Purkinje cells with abnormal
perikaryal morphology (Fig. 3d) and the percentage of
Purkinje cells with SMI-34 positive perikarya (Fig. 3e)
were significantly elevated in FRDA cases compared to
controls (p < 0.05). Dendritic arborisation of Purkinje
cells is a critical determinant of neuronal connectivity
and health [7, 34]. To investigate changes in dendritic
arborisation, the number of dendrites at increasing dis-
tances (20-μm increments) from the Purkinje cell peri-
karyon was counted (Fig. 3g). Again no differences in
dendritic transections were found in FRDA cases com-
pared to controls (p <0.05) (Fig. 3h).
Evidence of Purkinje cell structural remodelling and
myelin disruption in FRDA
Atypical compensatory responses of Purkinje cells to
axonal injury may occur in response to cerebellar injury.
In control and FRDA cases, structural remodelling of
Purkinje cell axons was observed with evidence of
hypertrophic axons, hypertrophic recurrent collaterals
and arciform fibres (Fig. 4a, b and c). Both axonal
branching and axonal sprouting were also visible in both
Purkinje cells with and without axonal torpedoes (Fig. 4a
and d). These structural changes were significantly
Fig. 2 Abnormal neurofilament phosphorylation within Purkinje cell axons in FRDA. a A representative image of the cerebellar folia from an FRDA
case showing Calbindin-D28K positive hypertrophic axons and axonal torpedoes expressing high levels of SMI-34. The hatched areas in (i) represents
the higher magnified images (ii/iii). White arrows in (i) indicate areas of Calbindin-D28K/SMI-34 co-expression. b 3-dimensional confocal
image of a Purkinje cell immunofluorescently labelled with Calbindin-D28K (green), SMI-34 (red) and DAPI nuclear stain (blue) (perikaryon
(white triangle/asterisk), axonal torpedo (white triangle), recurrent collateral (white arrow)). The hatched areas in (i) represents the higher
magnified images (ii/iii). c Quantification of SMI-34 positive torpedoes per Purkinje cell in FRDA and control cases. Results are expressed
as the mean +/- (SE) (*p < 0.05, comparing FRDA to control)
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Fig. 3 (See legend on next page.)
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elevated, when normalised to the Purkinje cell layer
length and/or Purkinje cell number, in FRDA cases com-
pared to controls (p <0.05) (Table 2).
Using MBP and Calbindin-D28k co-labelling, we also
observed significant changes in Purkinje cell axonal
myelination within the granular layer, with evidence of
myelin fragmentation and loss localised to areas of
axonal hypertrophy and axonal torpedoes (Fig. 4e-q).
Quantification of bi-nucleate Purkinje cell heterokaryons
Using Calbindin-D28k labelling and DAPI nuclear stain,
sections from FRDA cases were scanned along the entire
length of the Purkinje cell layer for Purkinje cells con-
taining two nuclei (bi-nucleate heterokaryons). Using
epifluorescence microscopy, we examined ≥2000 Pur-
kinje cells from each case (total = 22,829 Purkinje cells).
The location of each suspected bi-nucleate Purkinje cell
was noted and subsequently scanned using confocal
microscopy acquiring 0.20 μm serial sections throughout
the entire Purkinje cell soma (Fig. 5). Following con-
focal evaluation and serial reconstruction, bi-nucleate
Purkinje cells were found to be present in all FRDA
cases. The frequency of bi-nucleate Purkinje cells de-
tected in patients with FRDA was low (mean 0.215 %
+/- 0.043) (Fig. 5c). Comparing this to previously
published data reported by our research group, describ-
ing the frequency of bi-nucleate Purkinje cells detected in
the same control patient cohort (mean 0.024 % +/- 0.006)
[22], we report a significant increase in the incidence of
bi-nucleate Purkinje cells in FRDA when compared to
control cases (p <0.01) (Fig. 5c).
As previously reported [54], two distinct types of
nuclear morphology were observed in bi-nucleate Pur-
kinje cells; either a large Purkinje cell-like nucleus with
disperse chromatin and a large nucleolus or a smaller
nucleus (a little more than half the normal size) with
compact chromatin (Fig. 5b). In patients with FRDA the
majority (70.21 % +/-9.40) of bi-nucleate cells contained
two large Purkinje cell-like nuclei (p <0.05). All other bi-
nucleate Purkinje cells contained one large Purkinje cell-
like nucleus and a second smaller nucleus with compact
chromatin (Fig. 5b and d). Using correlative analysis, in
FRDA cases we found no significant correlations be-
tween the frequency of bi-nucleate Purkinje cells with
either patient age at death or the number of Calbindin-
D28K/SMI-34 torpedoes per Purkinje cell body (data not
shown).
Cerebellar inflammation in FRDA
Both experimentally in animal models [18] and human
disease [22] evidence suggests that inflammatory cues
promote BMDCs to fuse with Purkinje cells to form bi-
nucleated Purkinje cell heterokaryons. In control sec-
tions immuno-labelled for the macrophage/microglial
markers HLA-DP, DQ, DR, few positive cells were
detected throughout the cerebellar folia (Fig. 6a and b).
In FRDA cases, the overall frequency of HLA-DP, DQ,
DR-positive microglia was highly variable between
patients and no significant differences in microglial
numbers were observed, in both the white matter and
grey matter regions, between FRDA and control cases
(Fig. 6a and b).
Using correlative analysis to investigate the relation-
ship between microglial numbers and the incidence of
bi-nucleated Purkinje cells, we found a significant posi-
tive correlations in the grey matter between the levels of
HLA-DP, DQ, DR-positive cells and both the frequency
of total bi-nucleate Purkinje cells and bi-nucleate Pur-
kinje cells containing one large and a second smaller
nucleus (p <0.05) (Fig. 6c). No correlation between
HLA-DP, DQ, DR-positive cells and the frequency of
bi-nucleate Purkinje cells containing two large nuclei
was observed.
Discussion
Here we present a pathological study showing novel
and fundamental insights into Purkinje cell injury,
remodelling and spontaneous repair in FRDA. We
provide evidence of significant injury to the Purkinje
cell axonal compartment with relative preservation of the
(See figure on previous page.)
Fig. 3 Analysis of both the Purkinje cell perikaryal and dendritic compartments in FRDA. a 3-dimensional confocal image of a FRDA case depicting
a Purkinje cell immunofluorescently labelled with Calbindin-D28K (green) and DAPI nuclear stain (blue). The hatched areas in (i) represents the higher
magnified images (ii; dendritic compartment) and (iii; perikaryal compartment (white arrow)). Quantification of (b) Purkinje cells per mm in FRDA
and control cases; (c) Purkinje cell perikaryon cell size categorised into: total Purkinje cells in FRDA (FRDA), Purkinje cells in FRDA with an axon torpedo
(FRDA torpedo) and total Purkinje cells in control cases; (d) Purkinje cells with an abnormal perikaryal morphology; and (e) Purkinje cells with SMI-34
positive perikarya. f, (i) Purkinje cell with a normal perikaryon morphology (white triangle) and a Purkinje cell with an axon torpedo
presenting with an abnormal (deflated and shrunken appearance) perikaryal morphology (white arrow). The hatched areas in (i) represents
the higher magnified images (ii) and (iii) showing the shrunken Purkinje cell with axonal (white arrow) and perikaryal/dendritic SMI-34
accumulation (white triangles). g A representative image depicting how changes in dendritic arborisation were investigated. Concentric
quarter circles (with increasing diameter of 20 μm) were aligned on the centre of each Purkinje cell perikaryon and the number of times
each circle transected a dendrite was counted. The number of transections per mm at each distance was calculated. The hatched areas in (i) represents
the higher magnified image (ii). h Quantification of the number of dendritic transections per mm at increasing distances from the cell perikaryon in
FRDA and control cases. Results are expressed as the mean +/- (SE) (**p < 0.01, *p < 0.05, ns (not significant), comparing FRDA to control)
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Fig. 4 Purkinje cells in FRDA show indications of both axonal remodelling and myelin disruption. Unless stated, all cerebellar images are from
FRDA cases. a-d Sections are DAB (brown) immuno-labelled with Calbindin-D28K and counterstained with haematoxylin (blue). e-q Sections are
immunofluorescently labelled with Calbindin-D28K (green) and MBP (red). The hatched areas in a, b, c, d represents the higher magnified
images (i), (ii), (iii), (iv) respectively. a Axonal thickening and branching (i; black arrow). b Thickening of both axon (ii; black triangle) and recurrent
collateral (ii; black arrow). c Hypertrophic axon with arciform profile (iii; black arrow). d Axonal branching with terminal sprouting (iv; black
arrows). e A typically ‘normal’ Purkinje cell axon, from a control case, projecting from the perikaryon (white arrow), through the granular layer
where it become myelinated (white triangle). The hatched area represents the higher magnified image f. Abnormal hypertrophic axons showing
either g fragmented myelin along the axon or h complete myelin loss. i-k Purkinje cell axons showing both axonal hypertrophy and fragmented
myelin distal to axon torpedoes. l A Purkinje cell torpedo absent of myelin and showing indications of sprouting (white triangle/asterisk).
m Myelinated (white triangle) and non-myelinated (white arrow) Purkinje cells torpedoes. n-q Purkinje cell torpedoes with varying
degrees of myelin fragmentation
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perikaryon and its extensive dendritic arborisation.
Axonal remodelling of Purkinje cells was clearly appar-
ent. We have also shown a considerable increase in the
frequency of bi-nucleate Purkinje cell heterokaryon for-
mation in FRDA cases. This is the first time in humans
that Purkinje cell fusion and heterokaryon formation in
the brain has been reported in a genetic condition. We
also provide evidence that heterokaryon formation is in-
fluenced by underlying levels of cerebellar inflammation
associated with the disease. Our results together dem-
onstrate the Purkinje cell’s unique plasticity and regen-
erative potential in response to damage.
Atrophy of the dentate nucleus, which receives inhibi-
tory GABA-ergic inputs from Purkinje cells originating
within the cerebellar hemispheres, is the most significant
change seen within the central nervous system of pa-
tients with FRDA [26–28, 30, 31, 49]. In FRDA cases,
where the dentate nucleus was visible, we observed
Table 2 Structural remodelling of Purkinje cell axons in both FRDA and control cases
Axonal change Comparator Control cases (Mean +/-SE (median)) FRDA cases (Mean +/-SE (median)) Significance (p value)
Hypertrophic axons Length 0.279 +/- 0.216 (0.298) 1.642 +/- 0.659 (1.028) p < 0.010
Purkinje cells 0.016 +/- 0.007 (0.010) 0.054 +/- 0.018 (0.036) p < 0.050
Hypertrophic recurrent collaterals Length 0.115 +/- 0.038 (0.118) 0.457 +/- 0.143 (0.396) p < 0.050
Purkinje cells 0.003 +/- 0.001 (0.003) 0.015 +/- 0.004 (0.011) p < 0.050
Arciform fibres Length 0.029 +/- 0.014 (0.023) 0.158 +/- 0.052 (0.138) p < 0.050
Purkinje cells 0.001 +/- 0.001 (0.001) 0.005 +/- 0.001 (0.004) p < 0.050
Axonal branching Length 0.064 +/- 0.024 (0.060) 0.271 +/- 0.088 (0.261) p = 0.082
Purkinje cells 0.002 +/- 0.001 (0.002) 0.009 +/- 0.003 (0.006) p < 0.050
Axonal sprouting Length 0.062 +/- 0.027 (0.060) 0.226 +/- 0.078 (0.172) p = 0.052
Purkinje cells 0.002 +/- 0.001 (0.002) 0.006 +/- 0.001 (0.007) p < 0.050
The frequency of axonal structural changes within the granular and Purkinje cell layers of both control and FRDA cases. All axonal changes are expressed as either
frequency per standardized unit length of the Purkinje cell layer (100 μm) (Length) or frequency per Purkinje cell (Purkinje cells). Comparisons between control and
FRDA were analysed using Mann-Whitney U tests
Fig. 5 An increase in bi-nucleate Purkinje cells is evident within the cerebellum of FRDA cases. a 3-dimensional confocal image of a bi-nucleate
Purkinje cell immunofluorescently labelled with Calbindin-D28K (green) and DAPI nuclear stain (blue). The hatched area in (i) represents the higher
magnified images (ii/iii). b A representative image of a bi-nucleate Purkinje cell containing two large Purkinje cell-like nuclei (Big/Big)
and a bi-nucleate Purkinje cell with one large Purkinje cell-like nucleus and one smaller nucleus with compact chromatin (Big/Small).
c Quantification of bi-nucleate Purkinje cells in FRDA cases. d Quantification of bi-nucleate Purkinje cells in FRDA cases categorised by their nuclear
phenotype (Big/Big) or (Big/Small). Results are expressed as the mean +/- (SE) (**p < 0.01, comparing FRDA to control or Big/Big to Big/Small)
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archetypal neuronal loss accompanied by sites of gru-
mose degeneration. This pathological transformation la-
belled positively for Calbindin-D28k demonstrating that
abnormal axon terminals were of Purkinje cell origin.
The resulting synaptic detachment of Purkinje cell axon
terminals from degenerating neurons within the dentate
nucleus would likely result in a retrograde change and a
lack of synaptic contact with the efferent target may lead
to trans-neuronal degeneration of the Purkinje cell.
However, contrary to pathological nomenclature, recent
reports suggest grumose degeneration may actually be a
beneficial phenomenon in which Purkinje cells escape
retrograde atrophy by producing new axonal sprouts
that establish contact with small surviving neurons
where they form reparative grumose clusters [30].
Indeed, there were marked changes to the Purkinje cell
axonal compartment, with abnormal axonal phosphoryl-
ation and abundant axonal thickening/formation of
axonal torpedoes within the granular cell layer. It is
thought in disease states that abnormal accumulation of
the axonal structural components leads to morpho-
logical changes within the axon, and depending on the
underlying disease mechanism, the accumulated material
can differ [35, 57]. The axon torpedo (a fusiform swell-
ing of the axon) is generally characterised by a central
accumulation of disoriented neurofilaments, which dis-
place the mitochondria and endoplasmic reticular ele-
ments to the periphery [37]. Neurofilament structures
are essential for axonal maintenance and both antero-
grade and retrograde axonal transport. It is conceivable
that loss of dentate nucleus neurons results in localised
failures of axonal transport causing the build-up of
transported proteins and axonal swelling [9]. We found
frequent phosphorylated neurofilament accumulation
within both hypertrophic axons and axon torpedoes, and
to a lesser extent within the perikarya. Neurofilament
phosphorylation and rates of axonal transport inversely
correlate, this again signifying an impaired axonal
Fig. 6 Microglial numbers within cerebellar grey matter regions positively correlate with the incidence of bi-nucleate Purkinje cells. a Levels of
HLA-DP, DQ, DR positive cells within the cerebellar white and grey matter regions of FRDA and control cases. b Representative images of
HLA-DP, DQ, DR positive cells (DAB (brown) immuno-labelled and counterstained with haematoxylin (blue)) within the cerebellar folia of FRDA
and control cases. The dashed inset is a higher magnified image depicting microglial morphology in a FRDA case showing microglia with both
enlarged perikarya and thicker processes. c Correlations and linear regression analysis between microglial cell numbers (in both the white matter
and grey matter) and the frequency of total bi-nucleate Purkinje cells, bi-nucleate Purkinje cells with two large Purkinje cell-like nuclei (Big/Big)
or bi-nucleate Purkinje cells with one large Purkinje cell-like nucleus and one smaller nucleus with compact chromatin (Big/Small). Results are
expressed as the mean +/- (SE). R2 = Pearson’s correlation coefficient of determination. (ns (not significant), comparing FRDA to control)
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transport within these areas [19, 41]. It is not known
pathologically exactly how these neurofilaments become
aberrantly phosphorylated, however accumulation of phos-
phorylation is a hallmark of several neurodegenerative con-
ditions, including ALS [40], Alzheimer’s disease [50] and
multiple sclerosis [16, 44]. Elevated phosphorylated neurofi-
laments detected in the CSF can be used as early protein
biomarkers in disease and even correlate with clinical dis-
ability [42], together highlighting the critical role neurofila-
ment changes have on both axonal damage and
neurodegenerative processes.
The typical response of most neurons to axonal injury
is a cell body reaction involving a complex sequence of
molecular and genetic changes that initially sustain com-
pensatory and regenerative responses, but eventually be-
come regressive leading to atrophy or cell death [45].
However, cerebellar atrophy is not a major pathological
characteristic associated with FRDA. Purkinje cell sur-
vival was not significantly reduced in FRDA cases and
morphological analysis showed no signs of pruning to
the Purkinje cell dendritic arbour. In FRDA cases the
global perikaryon size was also unchanged, however in a
sub-group of Purkinje cells with an associated axon tor-
pedo, a significant reduction in perikaryon size was evi-
dent. Elevated levels of Purkinje cell perikarya with
abnormal deflated/shrunken morphologies and/or SMI-
34 positivity were observed, which may indicate early
changes leading to cell death or possible compensatory
structural modifications due to the close proximity of
the axonal obstruction. Purkinje cells have an inherent
and atypical resistance to stress within the CNS and
often survive despite injury to their axon [12]. Purkinje
cells in FRDA cases showed remarkable morphological
plasticity in response to injury in the form of axonal
branching, arciform fibres, hypertrophic recurrent collat-
erals and axonal sprouting. These changes were abun-
dant and are thought to allow the Purkinje cell to draw
retrograde trophic support by way of either reorganisa-
tion of the intra-cortical plexus or establishing new con-
nections with other Purkinje cells or neurons in the
surrounding granular layer, thus dampening down a cell
body response to injury [43].
Remodelling of the Purkinje cell axon can be induced
by extrinsic inhibitory cues such as myelin-associated
molecules. For example, blocking of myelin-associated
neurite growth inhibitory protein (Nogo-A) binding to it
receptor complex situated on the axonal membrane, can
induce prolific spouting in Purkinje cells from both the
corticofugal axon and the intra-cortical plexus [5, 14].
Nogo proteins in the adult CNS are now known to be
negative regulators of neurite growth, leading to
stabilization of the CNS wiring in the healthy brain at
the expense of extensive plastic rearrangements and
regeneration after injury [47]. In relation, we observed
significant amounts of both myelin fragmentation and
loss localised to both hypertrophic axons and axonal tor-
pedoes within the granular layer. It could therefore be
hypothesized that an increase in axon calibre disrupts
myelin/axon interactions and is, at least in part, respon-
sible for initiating a cell survival response through pro-
moting axonal sprouting and remodelling.
Of major relevance to ataxia is the potentially neuro-
regenerative process of BMDCs migrating into the CNS
and fusing with, in particular, Purkinje cells within the
cerebellum. A process in which the two distinct cells
fuse together to become a single cell, resulting in trans-
fer and amalgamation of nuclear material, to form bi-
nucleate or mono-nucleate cells. A key observation in
this study was evidence of Purkinje cell fusion in
diseased FRDA brains through detecting bi-nucleate
Purkinje cell heterokaryons; the frequency of these cells
in FRDA being significantly higher than that previously
reported in control cases [22]. The phenomenon of
BMDCs fusing with Purkinje cells has been observed
in a variety of experimental models of cerebellar dis-
ease [2, 3, 8, 10, 11] and the presence of cell fusion,
shown also by detection of increased bi-nucleated
neurons, has been described in a variety of human
CNS diseases, including multiple sclerosis [22], Alz-
heimer’s disease [58] and Spino-olivo-ponto-cerebello-
nigral atrophy [20].
Purkinje cells are generated only during early brain
development and in contrast to other neurons there is
no evidence of their generation after birth [53]. Under
normal physiological conditions Purkinje cell fusion
seems to occur at very low levels [53, 54]. In FRDA
cases, we found no correlation between patient age and
the frequency of fusion, though experimentally, the inci-
dence of cell fusion in the brain is enhanced with age,
radiation exposure, inflammation, chemotherapeutic
drugs and even selective damage to the neurons them-
selves [13, 18, 21, 36, 54, 55]. This raises the possibility
that fusion represents a rescue process, both in FRDA and
other neurological conditions, by which BMDCs migrate
into the CNS and donate genetic material to injured
highly complex cell types that otherwise cannot be re-
placed in adults through classical modes of trans-
differentiation [4, 48]. Indeed, in organs other than the
brain, fusion clearly represents a crucial process by which
degenerating cells with genetic damage can be rescued,
promoting their survival [32, 52, 56]. Using genetic
models of Purkinje cell degeneration, researchers
have explored the potential of using BMDCs to pro-
tect Purkinje cells. These studies have provided
compelling evidence for BM cell-mediated neuropro-
tective mechanisms, with a neurodegenerative micro-
environment appearing to augment Purkinje cell
fusion [2, 10, 11]. Further studies also showed that
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transplantation of enhanced green fluorescent protein
(EGFP)-expressing BMDCs directly into the cerebellum al-
leviates Purkinje cell degeneration in murine Niemann-Pick
Type C1 disease. Moreover, fusion between these BMDCs
and existing Purkinje cells led to the formation of electric-
ally active neurons with functional synaptic formation
within a neurodegenerative cerebellar environment [3].
Little is known concerning the regulatory mechanisms
behind controlling Purkinje cell fusion in response to
injury; however, inflammatory cues are known to play a
physiologically significant role. Fusion between Purkinje
cells and BMDCs occurs ordinarily at low levels, but the
incidence of fusion is substantially increased by chronic
inflammation [18, 21]. The mechanisms by which
inflammation enhances fusion are unclear, but the com-
bination of TNF-alpha and IFN-gamma particularly en-
hance the process in vitro [21]. We found the degree of
neuro-inflammation, characterised by increased microglial
cell numbers, to be highly variable within FRDA cases and
not significantly elevated compared to controls. In con-
trast to FRDA-affected cardiac tissue [29], the cerebellum
does not characteristically show a significant inflammatory
component, although microglial changes in ferritin immu-
noreactivity, morphology and frequency have previously
been reported [28, 31]. Interestingly, in the FRDA cases
used for our study, we did find a significant correlation
between microglial numbers within cerebellar grey matter
and the formation of bi-nucleate Purkinje cell hetero-
karyons. More specifically, microglial cell numbers corre-
lated with numbers of bi-nucleate Purkinje cells
harbouring both a large Purkinje cell-like nucleus with
disperse chromatin and a second smaller nucleus with
compact chromatin; a nuclear phenotype signifying a
recent fusion event; the donated nucleus yet to be repro-
grammed to finally assume the morphology of a Purkinje
cell nucleus. Purkinje cells are classically mono-nucleate
cells [38]. It is hypothesised that once fusion has occurred
the small dense donor nuclei is progressively repro-
grammed, causing it to become, over time, less dense and
compact, and finally to assume the morphology of the
Purkinje nucleus [54]. Hence, the nuclear phenotype of
fused cells can be an indication of heterokaryon maturity.
Due to the chronic nature of the disease, it is not surpris-
ing that the large majority of bi-nucleate cells in FRDA
cases contained two large Purkinje cell-like nuclei. How-
ever, finding an association between existing grey matter
microglial levels and recent fusion events provides
compelling evidence that local inflammatory cues, albeit
at the end stages of the disease, can promote Purkinje cell
fusion in humans.
Conclusion
Whether the observed changes to Purkinje cells in our
FRDA cohort are solely a response to depleted cellular
frataxin levels and/or loss of the dentate nucleus; or
alternatively, at least in part, a result of secondary damage
caused by hypoxic-ischemic injury (due to either cardiomy-
opathy or pulmonary complications as reported in our
FRDA cases) cannot be fully determined. As yet, the precise
functional significance of Purkinje cell plasticity in response
to stress/injury is also unknown. Nevertheless, it is likely to
be closely linked to the central role Purkinje cells play in
maintaining cerebellar function. It is tempting to speculate
the reasons for such phenomena; survival of Purkinje cells
in FRDA may be functionally irrelevant as neuronal loss
within the dentate nucleus blocks corticonuclear transmis-
sion. However, these fairly unique changes in response to
axonal injury may allow the Purkinje cell to convey its out-
put information through nearby intact neurons, or be a
neuroprotective process to prevent a further cascade of dis-
abling neurodegenerative changes, as would likely result
from a loss of Purkinje cells, within the cerebellar milieu.
More research into these mechanisms are warranted and
elucidating the biological pathways behind both neuronal
plasticity and cell fusion in disease could have significant
clinical implications in manipulating neuronal repair in re-
sponse to injury.
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